Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 217

Similar articles for PubMed (Select 21342243)

1.

ROSES: role of self-monitoring of blood glucose and intensive education in patients with Type 2 diabetes not receiving insulin. A pilot randomized clinical trial.

Franciosi M, Lucisano G, Pellegrini F, Cantarello A, Consoli A, Cucco L, Ghidelli R, Sartore G, Sciangula L, Nicolucci A; ROSES Study Group.

Diabet Med. 2011 Jul;28(7):789-96. doi: 10.1111/j.1464-5491.2011.03268.x.

PMID:
21342243
2.

Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes.

Farmer AJ, Perera R, Ward A, Heneghan C, Oke J, Barnett AH, Davidson MB, Guerci B, Coates V, Schwedes U, O'Malley S.

BMJ. 2012 Feb 27;344:e486. doi: 10.1136/bmj.e486.

3.

Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.

Blonde L, Merilainen M, Karwe V, Raskin P; TITRATE Study Group.

Diabetes Obes Metab. 2009 Jun;11(6):623-31. doi: 10.1111/j.1463-1326.2009.01060.x.

PMID:
19515182
4.

Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin.

Blak BT, Smith HT, Hards M, Curtis BH, Ivanyi T.

Diabet Med. 2012 Jul;29(7):e13-20. doi: 10.1111/j.1464-5491.2012.03586.x.

PMID:
22268988
6.

A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.

Nauck MA, Haastert B, Trautner C, Müller UA, Nauck MA, Heinemann L; Clinical Trials Study Group of the German Association for the Study of Diabetes (Deutsche Diabetes-Gesellschaft).

Diabetologia. 2014 May;57(5):868-77. doi: 10.1007/s00125-014-3168-1. Epub 2014 Jan 21.

PMID:
24445534
7.

Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.

Ushakova O, Sokolovskaya V, Morozova A, Valeeva F, Zanozina O, Sazonova O, Zhadanova E, Starceva M, Kazakova E, Saifullina M, Shapiro I, Tarasov A, Al-Tayar B, Starkova N.

Clin Ther. 2007 Nov;29(11):2374-84.

PMID:
18158078
9.

Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.

Farmer AJ, Wade AN, French DP, Simon J, Yudkin P, Gray A, Craven A, Goyder L, Holman RR, Mant D, Kinmonth AL, Neil HA; DiGEM Trial Group.

Health Technol Assess. 2009 Feb;13(15):iii-iv, ix-xi, 1-50. doi: 10.3310/hta13150.

10.

Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin.

Malanda UL, Welschen LM, Riphagen II, Dekker JM, Nijpels G, Bot SD.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD005060. doi: 10.1002/14651858.CD005060.pub3. Review.

PMID:
22258959
12.

Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study.

Guerci B, Drouin P, Grangé V, Bougnères P, Fontaine P, Kerlan V, Passa P, Thivolet Ch, Vialettes B, Charbonnel B; ASIA Group.

Diabetes Metab. 2003 Dec;29(6):587-94.

13.

Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

Ann Intern Med. 2008 Oct 21;149(8):531-9.

PMID:
18936501
14.

The impact of supported telemetric monitoring in people with type 2 diabetes: study protocol for a randomised controlled trial.

Wild S, Hanley J, Lewis S, McKnight J, McCloughan L, Padfield P, Paterson M, Pinnock H, McKinstry B.

Trials. 2013 Jul 6;14:198. doi: 10.1186/1745-6215-14-198.

15.

Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.

Harris MI; National Health and Nutrition Examination Survey (NHANES III).

Diabetes Care. 2001 Jun;24(6):979-82.

PMID:
11375356
16.

Evaluating once- and twice-daily self-monitored blood glucose testing strategies for stable insulin-treated patients with type 2 diabetes : the diabetes outcomes in veterans study.

Hoffman RM, Shah JH, Wendel CS, Duckworth WC, Adam KD, Bokhari SU, Dalton C, Murata GH; Diabetes Outcome in Veterans Study.

Diabetes Care. 2002 Oct;25(10):1744-8.

PMID:
12351471
17.

Fasting plasma glucose 6-12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis.

Karl D, Zhou R, Vlajnic A, Riddle M.

Diabet Med. 2012 Jul;29(7):933-6. doi: 10.1111/j.1464-5491.2012.03640.x.

18.
19.

Glycemic control with insulin glargine plus insulin glulisine versus premixed insulin analogues in real-world practices: a cost-effectiveness study with a randomized pragmatic trial design.

Levin PA, Zhang Q, Mersey JH, Lee FY, Bromberger LA, Bhushan M, Bhushan R.

Clin Ther. 2011 Jul;33(7):841-50. doi: 10.1016/j.clinthera.2011.05.091. Epub 2011 Jun 30.

PMID:
21719107
20.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk